Malignant disease is currently the leading cause of medical cardiac tamponade and is associated with a very poor prognosis.
No takes yet. Share an insight, caveat, or question.
Malignancy evaluation is warranted in cardiac tamponade; cohort data leaves open targeted interventions for this high-mortality subgroup.
Cornily et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: